Wolfsgruber, Steffen, Molinuevo, Jose Luis ORCID: 0000-0003-0485-6001, Wagner, Michael ORCID: 0000-0003-2589-6440, Teunissen, Charlotte E. ORCID: 0000-0002-4061-0837, Rami, Lorena ORCID: 0000-0002-7411-1921, Coll-Padros, Nina ORCID: 0000-0002-9282-6701, Bouwman, Femke H. ORCID: 0000-0002-0527-2270, Slot, Rosalinde E. R. ORCID: 0000-0002-5798-8916, Wesselman, Linda M. P. ORCID: 0000-0001-6758-4504, Peters, Oliver ORCID: 0000-0003-0568-2998, Luther, Katja ORCID: 0000-0002-3404-4680, Buerger, Katharina, Priller, Josef ORCID: 0000-0001-7596-0979, Laske, Christoph, Teipel, Stefan J. ORCID: 0000-0002-3586-3194, Spottke, Annika, Heneka, Michael T. ORCID: 0000-0003-4996-1630, Duezel, Emrah ORCID: 0000-0002-0139-5388, Drzezga, Alexander ORCID: 0000-0001-6018-716X, Wiltfang, Jens ORCID: 0000-0003-1492-5330, Sikkes, Sietske A. M. ORCID: 0000-0002-0161-3656, van der Flier, Wiesje M. ORCID: 0000-0001-8766-6224 and Jessen, Frank ORCID: 0000-0003-1067-2102 (2019). Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples. Alzheimers Res. Ther., 11. LONDON: BMC. ISSN 1758-9193

Full text not available from this repository.


IntroductionSubjective cognitive decline (SCD) in cognitively unimpaired older individuals has been recognized as an early clinical at-risk state for Alzheimer's disease (AD) dementia and as a target population for future dementia prevention trials. Currently, however, SCD is heterogeneously defined across studies, potentially leading to variations in the prevalence of AD pathology. Here, we compared the prevalence and identified common determinants of abnormal AD biomarkers in SCD across three European memory clinics participating in the European initiative on harmonization of SCD in preclinical AD (Euro-SCD).MethodsWe included three memory clinic SCD samples with available cerebrospinal fluid (CSF) biomaterial (IDIBAPS, Barcelona, Spain, n=44; Amsterdam Dementia Cohort (ADC), The Netherlands, n=50; DELCODE multicenter study, Germany, n=42). CSF biomarkers (amyloid beta (A)42, tau, and phosphorylated tau (ptau181)) were centrally analyzed in Amsterdam using prespecified cutoffs to define prevalence of pathological biomarker concentrations. We used logistic regression analysis in the combined sample across the three centers to investigate center effects with regard to likelihood of biomarker abnormality while taking potential common predictors (e.g., age, sex, apolipoprotein E (APOE) status, subtle cognitive deficits, depressive symptoms) into account.ResultsThe prevalence of abnormal A42, but not tau or ptau181, levels was different across centers (64% DELCODE, 57% IDIBAPS, 22% ADC; p<0.001). Logistic regression analysis revealed that the likelihood of abnormal A42 (and also abnormal tau or ptau181) levels was predicted by age and APOE status. For A42 abnormality, we additionally observed a center effect, indicating between-center heterogeneity not explained by age, APOE, or the other included covariates.ConclusionsWhile heterogeneous frequency of abnormal A42 was partly explained by between-sample differences in age range and APOE status, the additional observation of center effects indicates between-center heterogeneity that may be attributed to different recruitment procedures. These findings highlight the need for the development of harmonized recruitment protocols for SCD case definition in multinational studies to achieve similar enrichment rates of preclinical AD.

Item Type: Journal Article
CreatorsEmailORCIDORCID Put Code
Molinuevo, Jose LuisUNSPECIFIEDorcid.org/0000-0003-0485-6001UNSPECIFIED
Wagner, MichaelUNSPECIFIEDorcid.org/0000-0003-2589-6440UNSPECIFIED
Teunissen, Charlotte E.UNSPECIFIEDorcid.org/0000-0002-4061-0837UNSPECIFIED
Rami, LorenaUNSPECIFIEDorcid.org/0000-0002-7411-1921UNSPECIFIED
Coll-Padros, NinaUNSPECIFIEDorcid.org/0000-0002-9282-6701UNSPECIFIED
Bouwman, Femke H.UNSPECIFIEDorcid.org/0000-0002-0527-2270UNSPECIFIED
Slot, Rosalinde E. R.UNSPECIFIEDorcid.org/0000-0002-5798-8916UNSPECIFIED
Wesselman, Linda M. P.UNSPECIFIEDorcid.org/0000-0001-6758-4504UNSPECIFIED
Peters, OliverUNSPECIFIEDorcid.org/0000-0003-0568-2998UNSPECIFIED
Luther, KatjaUNSPECIFIEDorcid.org/0000-0002-3404-4680UNSPECIFIED
Priller, JosefUNSPECIFIEDorcid.org/0000-0001-7596-0979UNSPECIFIED
Teipel, Stefan J.UNSPECIFIEDorcid.org/0000-0002-3586-3194UNSPECIFIED
Heneka, Michael T.UNSPECIFIEDorcid.org/0000-0003-4996-1630UNSPECIFIED
Duezel, EmrahUNSPECIFIEDorcid.org/0000-0002-0139-5388UNSPECIFIED
Drzezga, AlexanderUNSPECIFIEDorcid.org/0000-0001-6018-716XUNSPECIFIED
Wiltfang, JensUNSPECIFIEDorcid.org/0000-0003-1492-5330UNSPECIFIED
Sikkes, Sietske A. M.UNSPECIFIEDorcid.org/0000-0002-0161-3656UNSPECIFIED
van der Flier, Wiesje M.UNSPECIFIEDorcid.org/0000-0001-8766-6224UNSPECIFIED
Jessen, FrankUNSPECIFIEDorcid.org/0000-0003-1067-2102UNSPECIFIED
URN: urn:nbn:de:hbz:38-159126
DOI: 10.1186/s13195-018-0463-y
Journal or Publication Title: Alzheimers Res. Ther.
Volume: 11
Date: 2019
Publisher: BMC
Place of Publication: LONDON
ISSN: 1758-9193
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Sonstiges > Zentrum für Versorgungsforschung Köln
Subjects: Medical sciences Medicine
Uncontrolled Keywords:
Clinical Neurology; NeurosciencesMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/15912


Downloads per month over past year



Actions (login required)

View Item View Item